Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,157
Closed -$5.92K 3748
2022
Q4
$5.92K Sell
6,157
-90,732
-94% -$128K ﹤0.01% 3522
2022
Q3
$211K Buy
96,889
+687
+0.7% +$2.37K ﹤0.01% 3224
2022
Q2
$337K Buy
96,202
+781
+0.8% +$2.92K ﹤0.01% 3097
2022
Q1
$481K Buy
95,421
+6,203
+7% +$31.4K ﹤0.01% 3006
2021
Q4
$559K Sell
89,218
-4,253
-5% -$29K ﹤0.01% 3738
2021
Q3
$744K Sell
93,471
-25,194
-21% -$207K ﹤0.01% 3556
2021
Q2
$889K Sell
118,665
-5,740
-5% -$40.1K ﹤0.01% 3480
2021
Q1
$753K Sell
124,405
-199,303
-62% -$1.53M ﹤0.01% 3500
2020
Q4
$1.85M Buy
323,708
+305,331
+1,661% +$1.94M ﹤0.01% 2884
2020
Q3
$122K Buy
+18,377
New +$164K ﹤0.01% 3906
2014
Q3
Sell
-1,076
Closed -$33K 4662
2014
Q2
$33K Sell
1,076
-3,841
-78% -$160K ﹤0.01% 4612
2014
Q1
$330K Buy
+4,917
New +$304K ﹤0.01% 4023
2013
Q4
Sell
-5,908
Closed -$272K 4721
2013
Q3
$272K Buy
5,908
+10
+0.2% +$433 ﹤0.01% 3844
2013
Q2
$223K Buy
+5,898
New +$245K ﹤0.01% 3810

Other funds holding VXRT

Credit Suisse's VXRT Position: Q1 2023 in Review

Credit Suisse sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 6,157 shares — an estimated $5.92K sold.

Credit Suisse first reported a position in VXRT in Q2 2013 and held it in 14 quarters. The position peaked at $1.85M in Q4 2020. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • Credit Suisse reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 6,157 Vaxart shares in Q1 2023, an estimated $5.92K.
  • Credit Suisse first reported a position in Vaxart in Q2 2013 and held it in 14 quarters.
  • Credit Suisse's Vaxart position peaked at $1.85M in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.